Key statistics
As of last trade Oncology Institute Inc (TOI:NAQ) traded at 2.97, -39.14% below its 52-week high of 4.88, set on Oct 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.88 |
|---|---|
| High | 2.99 |
| Low | 2.76 |
| Bid | 2.96 |
| Offer | 2.97 |
| Previous close | 2.89 |
| Average volume | 1.23m |
|---|---|
| Shares outstanding | 98.38m |
| Free float | 84.52m |
| P/E (TTM) | -- |
| Market cap | 284.32m USD |
| EPS (TTM) | -0.643 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 18:36 GMT.
More ▼
- The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
- The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
- The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
- The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook
- The Oncology Institute Announces Leadership Promotions
- The Oncology Institute Announces Addition of Board Member Mark Stolper
- The Oncology Institute Announces Resignation of Board Member Gabe Ling
- The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
- Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration
- The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call
More ▼
